代表性成果
1、Kong X#, Chen J#, Xie W#, Brown S, Cai Y, Wu K, Fan D, Nie Y, Yegnasubramanian S, Tiedemann R, Tao Y, Yen R, Topper MJ, Easwaran H, Rothbart SB*, Xia L*, Baylin SB*, Defining UHRF1 Domains That Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties, Cancer Cell. 2019;35(4):633-648 2.
2、Kong X#, Liu J#, Li L, Yue L, Zhang L, Jiang H, Xie X*, Luo C*, Functional interplay between the RK motif and linker segment dictates Oct4-DNA recognition, Nucleic Acids Res. 2015;43(9):4381-92 3
3、Kong X#, Chen L#, Jiao L, Jiang X, Lian F, Lu J, Zhu K, Du D, Liu J, Ding H, Zhang N, Shen J, Zheng M, Chen K, Liu X, Jiang H, Luo C*. Astemizole arrests the proliferation of cancer cells by disrupting the EZH2-EED interaction of polycomb repressive complex 2, J Med Chem. 2014;57(22):9512-21
4、ang S, Kong X, Luo C, Zhao K, Li Z. DNMT1 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS, PCT/CN2023/073678（作为项目负责人，牵头完成成果转化，总金额1600万元）
巨春蓉
